Fenoxasulfone

CAS : 639826-16-7

Ref. 3D-PAB82616

Informations sur le produit

• Nom: Fenoxasulfone
• Synonymes: 639826-16-7, T5No Eutj C1 C1 Esw1R Bg Eg Do2
• CAS: 639826-16-7

Description

Fenoxasulfone is a potent inhibitor of cyclin-dependent kinases (CDKs) that has shown promise as an anticancer agent. It is an analog of the urine-derived CDK inhibitor roscovitine and has been found to induce apoptosis in cancer cells. Fenoxasulfone inhibits the activity of several CDKs, including CDK2, CDK4, and CDK9, which are involved in cell cycle regulation and transcriptional control. This inhibition leads to a decrease in tumor cell proliferation and an increase in cancer cell death. Fenoxasulfone has been tested in Chinese hamster ovary cells and human cancer cell lines and has shown significant antitumor activity. This drug may be useful for the treatment of various types of cancer, particularly those with high levels of CDK activity.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 366.3 g/mol
• Formule: C₁₄H₁₇Cl₂NO₄S
• Degré de pureté: Min. 95%